Expectant management of prostate cancer

Seminars in oncology nursing

Volumn 17, Issue 2, 2001, Pages 101-107

  Griffin, Andrew S ^a   O ‘Rourke, Maureen E ^b,c  

^a Lyndhurst Gynecologic Associates PA   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; DECISION MAKING; EDUCATION; HUMAN; HUMAN RELATION; LIFE EXPECTANCY; MALE; ONCOLOGY NURSING; PATIENT CARE PLANNING; PATIENT COMPLIANCE; PROGNOSIS; PROSTATE TUMOR; PSYCHOLOGICAL ASPECT; REVIEW; STANDARD; SURVIVAL RATE; TREATMENT OUTCOME;

DECISION MAKING; HUMANS; LIFE EXPECTANCY; MALE; NEOPLASM STAGING; ONCOLOGIC NURSING; PATIENT CARE PLANNING; PATIENT COMPLIANCE; PROFESSIONAL-PATIENT RELATIONS; PROGNOSIS; PROSTATIC NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0035344578     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonu.2001.23074     Document Type: Article

References (32)

1. Steinberg GD Bales GT Bredler CB An analysis of watchful waiting for clinically localized prostate cancer J Urol 159 1998 1431 1436
2. Stephenson RA PSA detection rates finish decline, begin to plateau Urol Times 5 2000 27 28
3. Landis SH Murray T Bolden S Cancer statistics CA Cancer J Clin 49 1999 8 31
4. Adolfsson J Deferred treatment for clinically localized prostate cancer Eur J Surg Oncol 21 1995 333 340
5. Scott R Mutchnik D Laskowski T Carcinoma of the prostate in elderly men: Incidence, growth characteristics and clinical significance J Urol 101 1969 602 605
6. Mettlin CJ Murphy GP Why is the prostate cancer death rate declining in the United States? Cancer 82 1998 249 251
7. Johansson JE Holmberg L Johansson S Fifteen year survival in prostate cancer: Results and identification of high-risk patient population JAMA 277 1997 467 471
8. Adolfsson J Cartensen J Lowhagen T Deferred treatment in clinically localized prostate carcinoma Br J Urol 69 1992 183 187
9. Aus G Hugosson J Norlen L Long-term survival and mortality in prostate cancer treated with non-curative intent J Urol 154 1995 460 465
10. Goodman CM Busttil A Chisholm GD Age, size, and grade of tumor predict prognosis in incidentally diagnosed carcinoma of the prostate Br J Urol 62 1988 576 580
11. Albertsen PC Fryback DG Storer BE Long-term survival among men with conservatively treated localized prostate cancer JAMA 274 1995 626 631
12. Chodak GW The role of watchful waiting in the management of localized prostate cancer J Urol 152 1994 1766 1768
13. American College of Physicians Clinical Guideline: Part III. Screening for prostate cancer Ann Intern Med 126 1997 480 484
14. United States Preventive Health Services Task Force Guide to Clinical Preventive Services ed 2 1996 Williams & Wilkins Baltimore, MD
15. Wilt TJ Brawer MK Early intervention or expectant management for prostate cancer: The prostate cancer intervention versus observation trial (PIVOT): A randomized trial comparing radical prostatectomy with expectant management for the treatment of clinically localized prostate cancer Semin Urol 13 1995 130 136
16. Hanks GE The Wilt et al article reviewed. PIVOT: The radiation oncologist's friend Oncology 11 1997 1139 1140
17. (abstr) Brausi M Palladin PD Latini A “Watchful waiting” for clinically localized prostate cancer: Long term results Eur Oncol 30 suppl 2 1996 225
18. Johsnsson JE Adami MD Anderson SO Natural history of localized prostate cancer: A population-based study in 233 untreated patients Lancet 1 1989 799
19. McLaren DB McKenzie M Duncan G Watchful waiting or watchful progression? Prostate specific antigen doubling times and clinical behavior in patients with early untreated prostate carcinoma Cancer 82 1998 342 348
20. Hugosson J Aus G Norlen L Surveillance is not a viable and appropriate treatment option in the management of localized prostate cancer Urol Clin North Am 23 1996 557 573
21. Litwin MS Hays RD Fink A Quality of life and treatment outcomes in men treated for localized prostate cancer JAMA 273 1995 129 135
22. Yarbro CH Ferrans CE Quality of life of patients with prostate cancer treated with surgery or radiation Oncol Nurs Forum 25 1998 685 693
23. Nam R Klotz IH Jewett MAS Prostate specific antigen velocity as a measure of the natural history of prostate cancer: Identification of a rapid riser subset Br J Urol 81 1998 100 104
24. Chodak GW Results of conservative management of clinically localized prostate cancer N Engl J Med 330 1994 242 248
25. Carter B Is watchful waiting an acceptable risk? Prog Prostate Cancer 9 suppl 1 2000 2
26. Middleton RG Thompson I Austenfeld MS Prostate Cancer Clinical Guidelines Panel summary report on the management of clinically localized prostate cancer J Urol 154 1995 2144 2148
27. Choo R PSA doubling time useful in patients on observation Urol Times 4 2000 15
28. Byar DP Corle DK Hormone therapy for prostate cancer: Results of the Veterans Administration Cooperative Urological Research Group Studies NCI Monogr 7 1988 165
29. Robinson MRG Complete androgen blockage: The EORTC experience comparing orchidectomy versus orchidectomy plus cyproterone acetate versus low-dose stilbestrol in the treatment of metastatic carcinoma of the prostate Murphy GP Khoury S Kuss R Proceedings of Second International Symposium on Prostate Cancer. Prostate Cancer Part A: Research Endocrine Treatment, and Histopathology 1987 Liss New York, NY 383 390
30. Crawford ED Eisenberger MA McLeod DG A controlled trial of leuprolide with and without flutamide in prostatic carcinoma N Engl J Med 321 1989 419 424
31. O'Rourke ME Prostate cancer treatment selection: The family decision process. Doctoral dissertation 1997 University of North Carolina Chapel Hill, NC
32. Curtis RC Coping with Prostate Cancer: The effects of family strength, sense of coherence, and spiritual resources. Doctoral dissertation 2000 University of North Carolina Greensboro, NC